Heartflow, Inc. 8-K

What Happened

• Heartflow, Inc. (filed 8-K on June 18, 2026) reported results of its June 16, 2026 Annual Meeting of Stockholders. Each Class I director nominee—Julie A. Cullivan and John C.M. Farquhar—was elected to a three‑year term expiring at the 2029 Annual Meeting. The stockholders also ratified PricewaterhouseCoopers LLP (PwC) as Heartflow’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

Key Details

• Julie A. Cullivan: For 51,986,481; Withheld 6,046,730; Broker Non‑Votes 11,550,151.
• John C.M. Farquhar: For 52,277,825; Withheld 5,755,386; Broker Non‑Votes 11,550,151.
• PwC ratification: For 68,735,861; Against 717,413; Abstained 130,088.
• Meeting date: June 16, 2026; director terms expire at the 2029 Annual Meeting.

Why It Matters

• Governance continuity: Election of both Class I nominees maintains the board’s composition and oversight for the next three years, which matters for corporate strategy and supervision.
• Audit continuity: Ratifying PwC confirms the company’s independent auditor for the 2026 fiscal year, affecting financial reporting and investor confidence.
• Vote context: The presence of broker non‑votes (11.55M) reflects shares held by brokers for which voting instructions were not received, a factor in contested or close governance votes.